Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance at Dec. 31, 2021	$ 321,084	$ 4	$ 417,363	$ (388)	$ (95,895)
Beginning balance, shares at Dec. 31, 2021		37,379,077
Issuance of common stock upon exercise of common stock options	309		309
Issuance of common stock upon exercise of common stock options, shares		419,949
Issuance of common stock under employee stock purchase plan	345		345
Issuance of common stock under employee stock purchase plan, shares		78,361
Stock-based compensation	10,606		10,606
Unrealized gain (loss) on available-for-sale securities	(1,568)			(1,568)
Net loss	(95,639)				(95,639)
Ending balance at Dec. 31, 2022	$ 235,137	$ 4	428,623	(1,956)	(191,534)
Ending balance, shares at Dec. 31, 2022		37,877,387
Issuance of common stock upon exercise of common stock options, shares	128,534
Issuance of common stock upon exercise of common stock options and vesting of restricted stock units	$ 167		167
Issuance of common stock upon exercise of common stock options and vesting of restricted stock units, shares		128,534
Issuance of common stock under employee stock purchase plan	326		326
Issuance of common stock under employee stock purchase plan, shares		166,682
Stock-based compensation	10,623		10,623
Unrealized gain (loss) on available-for-sale securities	1,607			1,607
Net loss	(117,672)				(117,672)
Ending balance at Dec. 31, 2023	$ 130,188	$ 4	$ 439,739	$ (349)	$ (309,206)
Ending balance, shares at Dec. 31, 2023		38,172,603